FDA Issues Warning Letter to Hemarus
October 16, 2024
October 16, 2024
WASHINGTON, Oct. 16 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Hemarus LLC:
* * *
To: Padmasree Chigurupati, Vice President of Quality and Regulatory Affairs, Hemarus LLC, 4600 Military Trail, Suite 224, Jupiter, FL 33458-4813, United States, padma@hemarus.com
Dear Ms. Chigurupati:
During an inspection of your firm, Hemarus LLC, located at 1295 NW 40th Avenue, Suite 20 . . .
* * *
To: Padmasree Chigurupati, Vice President of Quality and Regulatory Affairs, Hemarus LLC, 4600 Military Trail, Suite 224, Jupiter, FL 33458-4813, United States, padma@hemarus.com
Dear Ms. Chigurupati:
During an inspection of your firm, Hemarus LLC, located at 1295 NW 40th Avenue, Suite 20 . . .